机构:[a]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China重点科室诊疗科室神经病学中心神经病学中心首都医科大学附属天坛医院[b]China National Clinical Research Center for Neurological Diseases, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[c]Center of Stroke, Beijing Institute for Brain Disorders, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China
The role of OPA1-related mitochondrial fusion in brain reperfusion stress has remained elusive. The aim of our study is to explore whether melatonin alleviates cerebral IR injury by modulating OPA1-related mitochondrial fusion. We found that melatonin reduced infarct area and suppressed neuron death during reperfusion stress. Biological studies have revealed that IR-inhibited mitochondrial fusion was largely reversed by melatonin via upregulated OPA1 expression. Knocking down OPA1 abrogated the protective effects of melatonin on mitochondrial energy metabolism and mitochondrial apoptosis. In addition, we also found that melatonin modified OPA1 expression via the Yap-Hippo pathway; blockade of the Yap-Hippo pathway induced neuron death and mitochondrial damage despite treatment with melatonin. Altogether, our data demonstrated that cerebral IR injury is closely associated with defective OPA1-related mitochondrial fusion. Melatonin supplementation enhances OPA1-related mitochondrial fusion by activating the Yap-Hippo pathway, ultimately reducing brain reperfusion stress.
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|3 区医学
小类|3 区医学:研究与实验3 区药学
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
JCR分区:
出版当年[2017]版:
Q2PHARMACOLOGY & PHARMACYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[a]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[b]China National Clinical Research Center for Neurological Diseases, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[c]Center of Stroke, Beijing Institute for Brain Disorders, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China
通讯作者:
通讯机构:[a]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[b]China National Clinical Research Center for Neurological Diseases, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[c]Center of Stroke, Beijing Institute for Brain Disorders, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China[*1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119, Nansihuan West Road, Fengtai District, Beijing, 100070, China.
推荐引用方式(GB/T 7714):
Wei Na,Pu Yuehua,Yang Zhonghua,et al.Therapeutic effects of melatonin on cerebral ischemia reperfusion injury: Role of Yap-OPA1 signaling pathway and mitochondrial fusion[J].BIOMEDICINE & PHARMACOTHERAPY.2019,110:203-212.doi:10.1016/j.biopha.2018.11.060.
APA:
Wei, Na,Pu, Yuehua,Yang, Zhonghua,Pan, Yuesong&Liu, Liping.(2019).Therapeutic effects of melatonin on cerebral ischemia reperfusion injury: Role of Yap-OPA1 signaling pathway and mitochondrial fusion.BIOMEDICINE & PHARMACOTHERAPY,110,
MLA:
Wei, Na,et al."Therapeutic effects of melatonin on cerebral ischemia reperfusion injury: Role of Yap-OPA1 signaling pathway and mitochondrial fusion".BIOMEDICINE & PHARMACOTHERAPY 110.(2019):203-212